trial · primary record
PAS-004 Capsules
RAS Mutation
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 83 |
| Primary completion | 2027-09 |
| Primary endpoint | Evaluation of dose limiting toxicities (DLTs) |
| Registry ID | NCT06299839 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:27.435Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06299839
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.